Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Top Cited Papers
- 1 October 2009
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 30 (10), 972-976
- https://doi.org/10.1086/605922
Abstract
Objective.: To determine the attributable (direct) mortality and morbidity caused by carbapenem-resistant Klebsiella pneumoniae bacteremia.Design.: A matched retrospective, historical cohort design, using a stepwise procedure to stringendy match the best control subjects to the best case subjects.Setting.: A 1,000-bed tertiary-care university teaching hospital.Patients.: Case subjects were defined as adult patients with carbapenem-resistant K. pneumoniae bacteremia during the period from October 2005 through October 2008. Control subjects were defined as patients who were very similar to case subjects except that they did not have bacteremia.Methods.: Matching potential control subjects to case subjects was performed at a 1:1 ratio using a computerized record system. The criteria used included same hospitalization period, similar Charlson comorbidity index, same underlying disease, same age within 10 years, and same sex. Demographic and clinical characteristics were collected from medical records.Results.: During the study period, 319 patients developed an infection due to carbapenem-resistant K. pneumoniae. Of these 319 patients, 39 (12.2%) developed a bloodstream infection, for an overall rate of 0.59 episodes of carbapenem-resistant K. pneumoniae bacteremia per 10,000 patient-days. We excluded 7 patients from our study, leaving a total of 32 case subjects in our cohort. Case subjects were significandy more likely than control subjects (n = 32) to require care in an intensive care unit (12 case subjects [37.5%] vs 3 control subjects [9.4%]), ventilator support (17 case subjects [53.1%] vs 8 control subjects [25%]), and use of a central venous catheter (19 case subjects [59.4%] vs 9 control subjects [28.1%]). For case subjects, the crude mortality rate was 71.9% (ie, 23 of the 32 case subjects died); for control subjects, the crude mortality rate was 21.9% (ie, 7 of the 32 control subjects died) (P < .001. For case subjects, the attributable mortality was 50% (95% confidence interval [CI], 15.3%-98.6%). A mortality risk ratio of 3.3 (95% CI, 2.9-28.5) was found for case subjects with carbapenem-resistant K. pneumoniae bacteremia.Conclusions.: Patients with carbapenem-resistant K. pneumoniae require more intensive and invasive care. We have shown that the crude and attributable mortality rates associated with carbapenem-resistant K. pneumoniae bacteremia were striking.Keywords
This publication has 19 references indexed in Scilit:
- Metallo-β-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?International Journal of Antimicrobial Agents, 2009
- Appropriate vs. inappropriate antimicrobial therapyClinical Microbiology & Infection, 2008
- Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on MortalityAntimicrobial Agents and Chemotherapy, 2008
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Critical Care Medicine, 2007
- Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control studyJournal of Antimicrobial Chemotherapy, 2007
- Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in EnterobacteriaceaeJournal of Clinical Microbiology, 2007
- Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic FibrosisAntimicrobial Agents and Chemotherapy, 2005
- Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-AnalysisInfection Control & Hospital Epidemiology, 2003
- Attributable Mortality ofStenotrophomonas maltophiliaBacteremiaClinical Infectious Diseases, 2002
- Attributable Mortality of Bacteremia Associated with the Bacteroides fragilis GroupClinical Infectious Diseases, 1995